|
[1]
|
IDSA Sepsis Task Force. Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines[J]. Clin Infect Dis, 2018, 66:1631-1635. doi: 10.1093/cid/cix997 |
|
[2]
|
Klein Klouwenberg PM, Cremer OL, van Vught LA, et al. Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study[J]. Crit Care, 2015, 19: 319. doi: 10.1186/s13054-015-1035-1 |
|
[3]
|
Singer M, Deutschman CS, Seymour CW, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J].JAMA, 2016, 315: 801-810. doi: 10.1001/jama.2016.0287 |
|
[4]
|
Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program[J]. Crit Care Med, 2014, 42:1749-1755. doi: 10.1097/CCM.0000000000000330 |
|
[5]
|
Rhodes A, Evans LE, Alhazzani W, et al.Surviving Sepsis Campaign: International Guidelined for Management of Sepsis and Septic Shock:2016[J]. Crit Care Med, 2017, 43: 486-552. doi: 10.1097/CCM.0000000000002255 |
|
[6]
|
Alsolamy S, Al Salamah M, Al Thagafi M, et al.Diagnostic accuracy of a screening electronic alert tool for severe sepsis and septic shock in the emergency department[J].BMC Med Inform Decis Mak, 2014, 14:105. doi: 10.1186/s12911-014-0105-7 |
|
[7]
|
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41:580-637. doi: 10.1097/CCM.0b013e31827e83af |
|
[8]
|
Goulden R, Hoyle MC, Monis J, et al.qSOFA, SIRS and NEWS for predicting inhospital mortality and ICU admission in emergeney admissions treated as sepsis[J]. Emerg Med J, 2018, 35:345-349. doi: 10.1136/emermed-2017-207120 |
|
[9]
|
Gyang E, Shieh L, Forsey L, et al.A nurse-driven screening tool for the early identification of sepsis in an intermediate care unit setting[J].J Hosp Med, 2015, 10:97-103. doi: 10.1002/jhm.2291 |
|
[10]
|
Jones SL, Ashton CM, Kiehne L, et al.Reductions in sepsis mortality and costs after design and implementation of a nurse-based early recognition and response program[J].Jt Comm J Qual Patient Saf, 2015, 41:483-491. http://europepmc.org/abstract/MED/26484679 |
|
[11]
|
Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study[J].Crit Care Med, 2015, 43:3-12. |
|
[12]
|
Cockerill FR 3rd, Wilson JW, Vetter EA, et al. Optimal testing parameters for blood cultures[J]. Clin Infect Dis, 2004, 38:1724-1730. doi: 10.1086/421087 |
|
[13]
|
Lee A, Mirrett S, Reller LB, et al.Detection of Bloodstream Infections in Adults: How Many Blood Cultures Are Needed?[J]. J Clin Microbiol, 2007, 45: 3546-3548. doi: 10.1128/JCM.01555-07 |
|
[14]
|
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009, 49:1-45. doi: 10.1086/599376 |
|
[15]
|
Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials[J]. Clin Infect Dis, 2012, 54:1110-1122. doi: 10.1093/cid/cis021 |
|
[16]
|
Kumar A, Zarychanski R, Light B, et al.Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis[J].Crit Care Med, 2010, 38:1773-1785. doi: 10.1097/CCM.0b013e3181eb3ccd |
|
[17]
|
Brunkhorst FM, Oppert M, Marx G, et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial[J].JAMA, 2012, 307:2390-2399. doi: 10.1001/jama.2012.5833 |
|
[18]
|
de Jong E, van Oers JA, Beishuizen A, et al.Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial[J].Lancet Infect Dis, 2016, 16:819-827. doi: 10.1016/S1473-3099(16)00053-0 |
|
[19]
|
Prkno A, Wacker C, Brunkhorst FM, et al. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock—a systematic review and meta-analysis[J].Crit Care, 2013, 17:R291. doi: 10.1186/cc13157 |
|
[20]
|
Blot SI, Pea F, Lipman J.The effect of pathophysiology on pharmacokinetics in the critically ill patient — concepts appraised by the example of antimicrobial agents[J].Adv Drug Deliv Rev, 2014, 77:3-11. doi: 10.1016/j.addr.2014.07.006 |
|
[21]
|
Avni T, Levcovich A, Ad-El DD, et al. Prophylactic antibiotics for burns patients: systematic review and meta-analysis[J].BMJ, 2010, 340:c241. doi: 10.1136/bmj.c241 |
|
[22]
|
Barajas-Nava LA, López-Alcalde J, Roquéi Figuls M, et al. Antibiotic prophylaxis for preventing burn wound infection[J].Cochrane Database Syst Rev, 2013, 6:CD008738. http://europepmc.org/abstract/med/23740764 |
|
[23]
|
Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection[J].N Engl J Med, 2015, 372:1996-2005. doi: 10.1056/NEJMoa1411162 |
|
[24]
|
Eliakim-Raz N, Yahav D, Paul M, et al.Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials[J].J Antimicrob Chemother, 2013, 68:2183-2191. doi: 10.1093/jac/dkt177 |
|
[25]
|
Rattan R, Allen CJ, Sawyer RG, et al. Patients with complicated intra-abdominal infection presenting with sepsis do not require longer duration of antimicrobial therapy[J].J Am Coll Surg, 2016, 222:440-446. doi: 10.1016/j.jamcollsurg.2015.12.050 |
|
[26]
|
Hepburn MJ, Dooley DP, Skidmore PJ, et al. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis[J].Arch Intern Med, 2004, 164:1669-1674. doi: 10.1001/archinte.164.15.1669 |
|
[27]
|
Seymour CW, Liu VX, Iwashyna TJ, et al.[J].JAMA, 2016, 315:762-774. doi: 10.1001/jama.2016.0288 |
|
[28]
|
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J].JAMA, 2016, 315:775-787. doi: 10.1001/jama.2016.0289 |
作者投稿
专家审稿
编辑办公
邮件订阅
RSS
点击查看大图
下载:
